Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Bellmann-Strobl

Showing results (71-80 of 173) with videos related to

Pageof 18
Sort By:
The British Journal of Ophthalmology|March 8, 2011
Impairment of contrast visual acuity as a functional correlate of retinal nerve fibre layer thinning and total macular volume reduction in multiple sclerosisMarkus Bock, Alexander U Brandt, Jörn Kuchenbecker, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 11, 2021
Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disordersNoah Ayadi, Frederike C Oertel, Susanna Asseyer, et al.
Journal of Neurology|November 27, 2023
Body mass, neuro-hormonal stress processing, and disease activity in lean to obese people with multiple sclerosisLil Meyer-Arndt, Jelena Brasanac, Stefanie Gamradt, et al.
Frontiers in Immunology|December 19, 2019
Low-Density Granulocytes Are a Novel Immunopathological Feature in Both Multiple Sclerosis and Neuromyelitis Optica Spectrum DisorderLennard Ostendorf, Ronja Mothes, Sofie van Koppen, et al.
Multiple Sclerosis and Related Disorders|June 24, 2025
Neuroprotective role of high dose Vitamin D supplementation in multiple sclerosis: Sub-analysis of the EVIDIMS trialEnrique Gomez-Figueroa, Carlos Moreno-Bernardino, Priscilla Bäcker-Koduah, et al.
Scientific Reports|May 14, 2021
SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patientsLennard Ostendorf, Philipp Dittert, Robert Biesen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 4, 2017
Microstructural visual system changes in AQP4-antibody-seropositive NMOSDFrederike C Oertel, Joseph Kuchling, Hanna Zimmermann, et al.
Multiple Sclerosis and Related Disorders|June 14, 2019
Neural mechanisms of perceptual decision-making and their link to neuropsychiatric symptoms in multiple sclerosisMartin Weygandt, Janina Behrens, Jelena Brasanac, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 25, 2013
Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndromeTimm Oberwahrenbrock, Marius Ringelstein, Simon Jentschke, et al.
Iscience|September 8, 2023
Similar neural pathways link psychological stress and brain-age in health and multiple sclerosisMarc-Andre Schulz, Stefan Hetzer, Fabian Eitel, et al.
Pageof 18

Showing results (71-80 of 173) with videos related to

Sort By:
Pageof 18
The British Journal of Ophthalmology|March 8, 2011
Impairment of contrast visual acuity as a functional correlate of retinal nerve fibre layer thinning and total macular volume reduction in multiple sclerosisMarkus Bock, Alexander U Brandt, Jörn Kuchenbecker, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 11, 2021
Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disordersNoah Ayadi, Frederike C Oertel, Susanna Asseyer, et al.
Journal of Neurology|November 27, 2023
Body mass, neuro-hormonal stress processing, and disease activity in lean to obese people with multiple sclerosisLil Meyer-Arndt, Jelena Brasanac, Stefanie Gamradt, et al.
Frontiers in Immunology|December 19, 2019
Low-Density Granulocytes Are a Novel Immunopathological Feature in Both Multiple Sclerosis and Neuromyelitis Optica Spectrum DisorderLennard Ostendorf, Ronja Mothes, Sofie van Koppen, et al.
Multiple Sclerosis and Related Disorders|June 24, 2025
Neuroprotective role of high dose Vitamin D supplementation in multiple sclerosis: Sub-analysis of the EVIDIMS trialEnrique Gomez-Figueroa, Carlos Moreno-Bernardino, Priscilla Bäcker-Koduah, et al.
Scientific Reports|May 14, 2021
SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patientsLennard Ostendorf, Philipp Dittert, Robert Biesen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 4, 2017
Microstructural visual system changes in AQP4-antibody-seropositive NMOSDFrederike C Oertel, Joseph Kuchling, Hanna Zimmermann, et al.
Multiple Sclerosis and Related Disorders|June 14, 2019
Neural mechanisms of perceptual decision-making and their link to neuropsychiatric symptoms in multiple sclerosisMartin Weygandt, Janina Behrens, Jelena Brasanac, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 25, 2013
Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndromeTimm Oberwahrenbrock, Marius Ringelstein, Simon Jentschke, et al.
Iscience|September 8, 2023
Similar neural pathways link psychological stress and brain-age in health and multiple sclerosisMarc-Andre Schulz, Stefan Hetzer, Fabian Eitel, et al.
Pageof 18